Knott David M Jr »

Tg Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 45k 29.81
2021-12-31 $638k 34k 18.99

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Syndax Pharmaceutical Common (SNDX)
Xeris Biopharma Holdings Common (XERS)
Travere Therapeutics Common (TVTX)
Bridgebio Pharma Common (BBIO)
Protagonist Therapeutics Common (PTGX)
JPMorgan Chase & Co. Common (JPM)
Janus Henderson AAA CLO ETF Common (JAAA)
Viridian Therapeutics Common (VRDN)
Catalyst Pharmaceuticals Common (CPRX)
Cogent Biosciences Common (COGT)
Mersana Therapeutics Common (MRSN)
Arcus Biosciences Common (RCUS)

View all positions for Knott David M Jr

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
ClearBridge Advisors
Geode Capital Management
Soleus Capital Management
Susquehanna International
Goldman Sachs Group
Congress Asset Management
Jane Street
Citadel Advisors
Invesco
Hood River Capital Management
Pictet Asset Management Holding SA
Northern Trust

View all funds holding Tg Therapeutics